Anthracyclines and Early Breast Cancer: The End of an Era?

被引：16
作者：
Gianni, Luca [1 ,2 ]
机构：
[1] Ist Tumori Milano, Div Med Oncol, Milan, Italy
[2] Fdn Michelangelo, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 08期
关键词：
ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; FOLLOW-UP; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; EPIRUBICIN; DOCETAXEL; METHOTREXATE; PACLITAXEL;
D O I：
10.1200/JCO.2008.20.1640
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1155 / 1157
页数：3
相关论文
共 50 条
  • [11] Anthracyclines in the treatment of early breast cancer friend or foe?
    Vuger, Ana Tecic
    Tiscoski, Katsuki
    Apolinario, Thiago
    Cardoso, Fatima
    BREAST, 2022, 65 : 67 - 76
  • [12] The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures
    Du, Yueyao
    Zhou, Qiong
    Yin, Wenjin
    Zhou, Liheng
    Di, Genhong
    Shen, Zhenzhou
    Shao, Zhimin
    Lu, Jinsong
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (03) : 839 - 848
  • [13] Liposomal anthracyclines: Adjuvant and neoadjuvant therapy for breast cancer
    Campos, S
    ONCOLOGIST, 2003, 8 : 10 - 16
  • [14] Role of Anthracyclines in the Treatment of Early Breast Cancer
    Gianni, Luca
    Norton, Larry
    Wolmark, Norman
    Suter, Thomas M.
    Bonadonna, Gianni
    Hortobagyi, Gabriel N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) : 4798 - 4808
  • [15] The role of anthracyclines in the treatment of early breast cancer
    Greene, John
    Hennessy, Bryan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2015, 21 (03) : 201 - 212
  • [16] Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?
    Shah, Ami N.
    Gradishar, William J.
    ONCOLOGIST, 2018, 23 (10) : 1153 - 1161
  • [17] Anthracyclines Are a Critical Component of Adjuvant Chemotherapy Regimens for High-Risk Early Breast Cancer THE HENDERSON ARTICLE REVIEWED
    Morris, Patrick G.
    Hudis, Clifford A.
    Dang, Chau T.
    ONCOLOGY-NEW YORK, 2011, 25 (02): : 134 - 140
  • [18] The role of anthracyclines in the adjuvant therapy of breast cancer
    Thomssen, C
    ONKOLOGIE, 2000, 23 : 7 - 11
  • [19] The End of an Era: Shall We Move Forward?
    Dang, Chau
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (29) : 3849 - 3851
  • [20] Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer
    Schramm, Amelie
    Schochter, Fabienne
    Friedl, Thomas W. P.
    de Greqorio, Nikolaus
    Andergassen, Ulrich
    Alunni-Fabbroni, Marianna
    Trapp, Elisabeth
    Jaeger, Bernadette
    Heinrich, Georg
    Camara, Oumar
    Decker, Thomas
    Ober, Angelika
    Mahner, Sven
    Fehm, Tanja N.
    Pantel, Klaus
    Fasching, Peter A.
    Schneeweiss, Andreas
    Janni, Wolfgang
    Rack, Brigitte K.
    CLINICAL BREAST CANCER, 2017, 17 (04) : 279 - 285
12345